-
While there are still many questions about the ultimate efficacy of the drug, lecanemab, Dr. Arash Salardini said it could provide a path forward for new Alzheimer's treatments, like AZT was for HIV.
-
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.
-
A San Antonio researcher says increased omega-3 fatty acids for people in middle-age are linked to both larger hippocampal volumes and better scores on tests that assess abstract and logical thinking.
-
UT Health San Antonio and University Health have performed South Texas’ first surgery to treat Alzheimer’s.
-
Latinos are disproportionately impacted by Alzheimer’s. South Texas researchers want to find out whyMore than 5 million people are currently living with Alzheimer’s in the United States, and that figure is expected to triple by 2050. The University of Texas Health Science Center at San Antonio and The University of Texas Rio Grande Valley are teaming up to search for new treatments for this devastating disease, and possibly a cure.
-
A new Alzheimer's drug isn't reaching many patients. Doctors say reasons include its high cost, and lingering questions about its effectiveness.
-
Cancer is the leading cause of death among Latinos and this demographic also faces a greater risk for Alzheimer’s disease, but Latinos are largely underrepresented in clinical research trials. A program at UT Health San Antonio is working to close that gap.
-
After a decade of failure in treating Alzheimer's with drugs, the National Institutes of Health is funding a five-year effort in Seattle to learn more about how the disease starts in the brain.
-
The San Antonio Symphony will perform Hollywood Hits this Friday at the Tobin Center. Before they do, they’ll perform the show for a special crowd: people…
-
The Centers for Disease Control and Prevention (CDC) reports that by 2060 the number of Latinos age 65 and older is expected to nearly quadruple, and…